Goldman Sachs Group Inc Boston Scientific Corp Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 13,242,537 shares of BSX stock, worth $1.21 Billion. This represents 0.18% of its overall portfolio holdings.

Number of Shares
13,242,537
Previous 13,428,809 1.39%
Holding current value
$1.21 Billion
Previous $1.03 Billion 7.31%
% of portfolio
0.18%
Previous 0.18%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$72.96 - $84.0 $13.6 Million - $15.6 Million
-186,272 Reduced 1.39%
13,242,537 $1.11 Billion
Q2 2024

Aug 13, 2024
SELL
$67.33 - $77.71 $83.3 Million - $96.2 Million
-1,237,659 Reduced 8.44%
13,428,809 $1.03 Billion
Q1 2024

May 15, 2024
SELL
$57.6 - $68.62 $78.3 Million - $93.3 Million
-1,360,025 Reduced 8.49%
14,666,468 $1 Billion
Q4 2023

Feb 13, 2024
SELL
$48.64 - $57.81 $28.8 Million - $34.2 Million
-591,845 Reduced 3.56%
16,026,493 $926 Million
Q3 2023

May 14, 2024
BUY
$50.19 - $54.68 $29.7 Million - $32.4 Million
591,845 Added 3.69%
16,618,338 $877 Million
Q3 2023

Nov 14, 2023
SELL
$50.19 - $54.68 $108 Million - $118 Million
-2,152,877 Reduced 11.47%
16,618,338 $877 Million
Q2 2023

May 14, 2024
BUY
$49.72 - $54.64 $44.6 Million - $49 Million
897,259 Added 5.02%
18,771,215 $1.02 Billion
Q2 2023

Aug 14, 2023
BUY
$49.72 - $54.64 $44.6 Million - $49 Million
897,259 Added 5.02%
18,771,215 $1.02 Billion
Q1 2023

May 14, 2024
SELL
$45.09 - $50.03 $3.9 Million - $4.33 Million
-86,573 Reduced 0.48%
17,873,956 $894 Million
Q1 2023

May 11, 2023
SELL
$45.09 - $50.03 $3.9 Million - $4.33 Million
-86,573 Reduced 0.48%
17,873,956 $894 Million
Q4 2022

May 14, 2024
SELL
$39.56 - $47.22 $59.5 Million - $71 Million
-1,504,520 Reduced 7.73%
17,960,529 $831 Million
Q4 2022

Feb 13, 2023
SELL
$39.56 - $47.22 $59.5 Million - $71 Million
-1,504,520 Reduced 7.73%
17,960,529 $831 Million
Q3 2022

May 14, 2024
BUY
$36.71 - $109.66 $186 Million - $555 Million
5,062,939 Added 35.15%
19,465,049 $754 Million
Q3 2022

Nov 10, 2022
BUY
$36.71 - $109.66 $186 Million - $555 Million
5,062,939 Added 35.15%
19,465,049 $754 Million
Q2 2022

May 14, 2024
SELL
$35.24 - $47.1 $57.2 Million - $76.5 Million
-1,624,383 Reduced 10.14%
14,402,110 $537 Million
Q2 2022

Aug 15, 2022
SELL
$35.24 - $47.1 $121 Million - $162 Million
-3,443,340 Reduced 19.3%
14,402,110 $537 Million
Q1 2022

May 16, 2022
SELL
$40.9 - $45.1 $45.4 Million - $50.1 Million
-1,110,661 Reduced 5.86%
17,845,450 $790 Million
Q4 2021

Feb 14, 2022
BUY
$38.07 - $44.87 $102 Million - $120 Million
2,669,063 Added 16.39%
18,956,111 $805 Million
Q3 2021

Nov 10, 2021
BUY
$41.23 - $45.88 $672 Million - $747 Million
16,287,048 New
16,287,048 $707 Million

Others Institutions Holding BSX

# of Institutions
1,542
Shares Held
1.19B
Call Options Held
6.79M
Put Options Held
10.1M
View Full List

About BOSTON SCIENTIFIC CORP

BSX Quotes by TradingView
  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email